Skip to main content

Treatment of Wegener’s Granulomatosis with Intravenous Immunoglobulin

  • Chapter
ANCA-Associated Vasculitides

Abstract

We report about the treatment of eight patients with Wegener’s granulomatosis and one patient with systemic pANCA-associated vasculitis with a single course of high-dose intravenous immunoglobulin (IVIG). In 5 of 9 patients (55%) this resulted in significant clinical improvement, in two patients a decrease of the ANCA-titre was seen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS, 1992. Wegener granulomatosis: An analysis of 158 patients, Ann Intern Med 116: 488–498

    Article  PubMed  CAS  Google Scholar 

  • Imbach P, d’Apuzzo V, Baumgartner C et a1,1981. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood, Lancet, 1: 1228–1230

    Google Scholar 

  • Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM, 1991. Treatment of systemic vasculitis with pooled intravenous immunoglobulin, Lancet, 337: 1137–1139

    Article  PubMed  CAS  Google Scholar 

  • Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD, 1991. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis, Clin exp Immunol, 83: 298–303

    Article  PubMed  CAS  Google Scholar 

  • Schwartz SA, 1990. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders, J Clin Immunol, 10: 81–89

    Article  PubMed  CAS  Google Scholar 

  • Steppat D, Gross WL, 1989. Stage-adapted treatment of Wegener’s granulomatosis, Klin Wochenschr, 67: 666–671

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Richter, C., Schnabel, A., Csernok, E., Reinhold-Keller, E., Gross, W.L. (1993). Treatment of Wegener’s Granulomatosis with Intravenous Immunoglobulin. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_88

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9182-2_88

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9184-6

  • Online ISBN: 978-1-4757-9182-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics